Scientific Director, Global Health
Current-Investment strategy and portfolio management to tackle infectious disease-Innovation to drive Affordability & Access for global health impact
Please complete the CAPTCHA to continue
@wellcome.ac.uk
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Pete Gardner is listed as Drugs, Vaccines & Biologics R&D | Global Health Investment strategy | Access & Affordability at LifeArc, a company with 227 employees, based in London, England, United Kingdom. AeroLeads shows a work email signal at wellcome.ac.uk and a matched LinkedIn profile for Pete Gardner.
Pete Gardner previously worked as Scientific Director, Global Health at Lifearc and Fellow at Royal Society Of Biology. Pete Gardner holds Doctor Of Philosophy (Ph.D.), Immunology, Pass from Ucl.
This section adds company-level context without repeating Pete Gardner's masked contact details.
AeroLeads found 1 current-domain work email signal for Pete Gardner. Compare company email patterns before reaching out.
I’m passionate about new medicines for global health and realising the potential of cutting edge science & innovation to tackle infectious disease.Interests include:A) investing in innovation and the development and use of new, accessible, low-cost antibody products to tackle infectious disease in LMICs.B) embedding access early in product development and incentivising partners to take on ambitious access strategies. C) unlocking investment & scientific bottlenecks for Neglected Tropical Diseases I'm an Immunologist by doctoral training and translational scientist with broad experience of academic research, university teaching, biotech/pharma collaborations and science funding/strategy through to impact. - My research background is in studying antibodies to Malaria, neuro-inflammation and cell & gene therapies.I have leadership experience building strategic high impact biologics, vaccine and drug development portfolios from discovery through pre-clinical, IND-enabling and clinical stage up to Phase II; together with post authorisation clinical studies generating evidence to inform implementation policy.
Listed skills include Retinal Degeneration, Good Clinical Practice, Uveitis, Ocular Disease, and 41 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
London Area, United Kingdom
-Investment strategy and portfolio management to tackle infectious disease-Innovation to drive Affordability & Access for global health impact
London, England, United Kingdom
- Leading the Antibody & Immunity team:Strategy and delivery of Wellcome’s £18M investment portfolio in antibodies for global health.- strategic initiatives for global access- Cholera & Salmonella vaccine R&D- TB vaccine discovery- Support to Wellcome’s Infectious Disease Prevention activities including vaccine R&D and human infection studies.-Strategic.
London, United Kingdom
- Working across the pharma BD pathway to deliver impact for global public health - Leading Wellcome’s vaccine and research investments for Non-typhoidal Salmonella, building a £15M portfolio.- Managing partnerships across vaccine and drug development for infectious disease including for Malaria and Lassa fever- Liaising with key global stakeholders.
London, United Kingdom
Infection and Immuno-biology team (IIB)- Managing £250M Infectious Disease programme- Portfolio management and M&E- Liaising with grant applicants and awardees- Alliance management with strategic partners
TVR, Institute Of Ophthalmology, UCL, London
Translational Vision Lab (TVR Shima Group)- Pre-clinical models of Diabetic Retinopathy- Retinal progenitor populations - In vivo retinal imaging of leukocytes
Genetics Dept, Institute Of Ophthalmology, UCL, London
Robin Ali laboratory with Andrew Dick and Jim Bainbridge-investigation of AnxA1 in ocular inflammation-10 colour flow cytometry analysis of leukocyte populations-human T cell ELISPOT assays for gene therapy clinical trial-pre-clinical Immuno/toxicology data for MHRA clinical trial application-Design and development of high thoughput screening of.
Orbit Dept, Institute Of Ophthalmology, UCL, London
Calder laboratory with Pete Adamson and Andrew Dick-focus on translational therapies for ocular inflammatory disease such as uveitis-small molecule activation of SIRT1 for suppression of pathological T cells driving autoimmunity-experience collaborating with GSK
London, United Kingdom
Victor Tybulewicz and Jean Langhorne laboratories-Investigating the immune response to Malaria-B cells, plasma cells and antibody responses-Genetic modification of mice:both transgenic and knock-in
Hinxton, UK
Greg Elgar laboratory-Shotgun sequencing of the Takifugu rubbripes genome-Investigation of conserved non-coding elements
Other employees you can reach at lifearc.org. View company contacts for 227 employees →
Kaarina Malmstrom
Colleague at Lifearc
Parry Sound, Ontario, Canada, Canada
View →
PA
Parvez Akhtar
Colleague at Lifearc
Greater London, England, United Kingdom, United Kingdom
View →
CS
Christine Sanfelice
Colleague at Lifearc
Stevenage, England, United Kingdom, United Kingdom
View →
DD
Douglas Dunbar
Colleague at Lifearc
Edinburgh, Scotland, United Kingdom, United Kingdom
View →
MA
Mark Aylward
Colleague at Lifearc
Greater London, England, United Kingdom, United Kingdom
View →
IS
Ilan S.
Colleague at Lifearc
United Kingdom, United Kingdom
View →
RG
Rebecca Girling
Colleague at Lifearc
Stevenage, England, United Kingdom, United Kingdom
View →
AB
Asher Broadbent
Colleague at Lifearc
Stevenage, England, United Kingdom, United Kingdom
View →
GZ
George Zaderej
Colleague at Lifearc
South Bend, Indiana, United States, United States
View →
MI
Mark Irving
Colleague at Lifearc
Wembley, England, United Kingdom, United Kingdom
View →
Quick answers generated from the profile data available on this page.
Pete Gardner works for LifeArc.
Pete Gardner is listed as Drugs, Vaccines & Biologics R&D | Global Health Investment strategy | Access & Affordability at LifeArc.
AeroLeads has found 1 work email signal at @wellcome.ac.uk for Pete Gardner at LifeArc.
Pete Gardner is based in London, England, United Kingdom while working with LifeArc.
Pete Gardner has worked for Lifearc, Royal Society Of Biology, Wellcome Trust, City, University Of London, and Ucl.
Pete Gardner's colleagues at LifeArc include Kaarina Malmstrom, Parvez Akhtar, Christine Sanfelice, Douglas Dunbar, and Mark Aylward.
You can use AeroLeads to view verified contact signals for Pete Gardner at LifeArc, including work email, phone, and LinkedIn data when available.
Pete Gardner holds Doctor Of Philosophy (Ph.D.), Immunology, Pass from Ucl.
Pete Gardner is listed with skills including Retinal Degeneration, Good Clinical Practice, Uveitis, Ocular Disease, Retina, Gene Therapy, Cell, and Immunology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Pete Gardner you were looking for.